22/05/2019
Sunstone makes a non-revocable commitment to sell all shares in Nuevolution at a price of SEK 32.5 per share to Amgen, corresponding to SEK 332 million Sunstone today announced that its Life Science Ventures Fund I has made a non-revocable commitment to sell all...
12/03/2019
Trading in Ascelia Pharma’s shares on Nasdaq Stockholm commences tomorrow Nasdaq Stockholm AB has today decided to admit the shares of Ascelia Pharma AB (“Ascelia Pharma” or the “Company”) for trading on Nasdaq Stockholm with first day of trading tomorrow, Wednesday...
07/03/2019
Peter S The offering in Ascelia Pharma AB (“Ascelia Pharma” or the “Company”) in connection with the Initial Public Offering on Nasdaq Stockholm was significantly oversubscribed. The new share issue (the “Offering”) will provide Ascelia Pharma with approximately SEK...
22/02/2019
Arcoma: Omsättningen ökar 36%: fortsatta resultatförbättringar: Arcomas kvartalsrapport för fjärde kvartalet 2018 – bokslutskommuniké – finns att läsa här Download Full Press Release Press inquiries should be adressed to: Peter Benson, Msc Chairman & General...
21/02/2019
Ascelia Pharma publishes prospectus in connection with Initial Public Offering on Nasdaq Stockholm Ascelia Pharma AB (“Ascelia Pharma” or the “Company”) has decided to issue new shares to the general public in Sweden and Denmark as well as institutional investors in...
Side 19 af 20« Første«...10...1617181920»
We use cookies on the website sunstone.eu in order to generate statistics and to maximize user-friendliness and improve functionality. By using our website, you consent to our use of cookies. Click on cookie settings below if you wish to disable cookies. Or you can read more about what cookies are, how we use them and how you disable cookies Here.
Cookie settingsAccept Privacy & Cookies Policy
Recent Comments